 | • レポートコード：MRC2-11QY04785 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は全身感染症治療のグローバル市場について調査・分析したレポートです。種類別（抗菌、抗ウイルス、防カビ）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別全身感染症治療の競争状況、市場シェア ・世界の全身感染症治療市場：種類別市場規模 2015年-2020年（抗菌、抗ウイルス、防カビ） ・世界の全身感染症治療市場：種類別市場規模予測 2021年-2026年（抗菌、抗ウイルス、防カビ） ・世界の全身感染症治療市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の全身感染症治療市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の全身感染症治療市場分析：米国、カナダ ・ヨーロッパの全身感染症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの全身感染症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の全身感染症治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの全身感染症治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Merck & Co.、Pfizer、GlaxoSmithKline、Novartis、Johnson & Johnson、Sun Pharmaceuticals、Roche、Astra Zeneca、Wockhardt ltd、Mylan Pharma ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Systemic infection earns its name by being spread throughout the systems of the body. Systemic infections are not necessarily more severe than local infections.
Market Analysis and Insights: Global Systemic Infection Treatment Market
The global Systemic Infection Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Systemic Infection Treatment Scope and Market Size
Systemic Infection Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Systemic Infection Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
Merck & Co.
Pfizer
GlaxoSmithKline
Novartis
Johnson & Johnson
Sun Pharmaceuticals
Roche
Astra Zeneca
Wockhardt ltd
Mylan Pharma
Market segment by Type, the product can be split into
Antibacterial
Antiviral
Antifungal
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Systemic Infection Treatment Revenue
1.4 Market by Type
1.4.1 Global Systemic Infection Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Antibacterial
1.4.3 Antiviral
1.4.4 Antifungal
1.5 Market by Application
1.5.1 Global Systemic Infection Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Systemic Infection Treatment Market Perspective (2015-2026)
2.2 Global Systemic Infection Treatment Growth Trends by Regions
2.2.1 Systemic Infection Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Systemic Infection Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Systemic Infection Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Systemic Infection Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Systemic Infection Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Systemic Infection Treatment Players by Market Size
3.1.1 Global Top Systemic Infection Treatment Players by Revenue (2015-2020)
3.1.2 Global Systemic Infection Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Systemic Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Systemic Infection Treatment Market Concentration Ratio
3.2.1 Global Systemic Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Systemic Infection Treatment Revenue in 2019
3.3 Systemic Infection Treatment Key Players Head office and Area Served
3.4 Key Players Systemic Infection Treatment Product Solution and Service
3.5 Date of Enter into Systemic Infection Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Systemic Infection Treatment Historic Market Size by Type (2015-2020)
4.2 Global Systemic Infection Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Systemic Infection Treatment Market Size by Application (2015-2020)
5.2 Global Systemic Infection Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Systemic Infection Treatment Market Size (2015-2020)
6.2 Systemic Infection Treatment Key Players in North America (2019-2020)
6.3 North America Systemic Infection Treatment Market Size by Type (2015-2020)
6.4 North America Systemic Infection Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Systemic Infection Treatment Market Size (2015-2020)
7.2 Systemic Infection Treatment Key Players in Europe (2019-2020)
7.3 Europe Systemic Infection Treatment Market Size by Type (2015-2020)
7.4 Europe Systemic Infection Treatment Market Size by Application (2015-2020)
8 China
8.1 China Systemic Infection Treatment Market Size (2015-2020)
8.2 Systemic Infection Treatment Key Players in China (2019-2020)
8.3 China Systemic Infection Treatment Market Size by Type (2015-2020)
8.4 China Systemic Infection Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Systemic Infection Treatment Market Size (2015-2020)
9.2 Systemic Infection Treatment Key Players in Japan (2019-2020)
9.3 Japan Systemic Infection Treatment Market Size by Type (2015-2020)
9.4 Japan Systemic Infection Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Systemic Infection Treatment Market Size (2015-2020)
10.2 Systemic Infection Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Systemic Infection Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Systemic Infection Treatment Market Size by Application (2015-2020)
11 India
11.1 India Systemic Infection Treatment Market Size (2015-2020)
11.2 Systemic Infection Treatment Key Players in India (2019-2020)
11.3 India Systemic Infection Treatment Market Size by Type (2015-2020)
11.4 India Systemic Infection Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Systemic Infection Treatment Market Size (2015-2020)
12.2 Systemic Infection Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Systemic Infection Treatment Market Size by Type (2015-2020)
12.4 Central & South America Systemic Infection Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Systemic Infection Treatment Introduction
13.1.4 Abbott Laboratories Revenue in Systemic Infection Treatment Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Merck & Co.
13.2.1 Merck & Co. Company Details
13.2.2 Merck & Co. Business Overview
13.2.3 Merck & Co. Systemic Infection Treatment Introduction
13.2.4 Merck & Co. Revenue in Systemic Infection Treatment Business (2015-2020)
13.2.5 Merck & Co. Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Systemic Infection Treatment Introduction
13.3.4 Pfizer Revenue in Systemic Infection Treatment Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Details
13.4.2 GlaxoSmithKline Business Overview
13.4.3 GlaxoSmithKline Systemic Infection Treatment Introduction
13.4.4 GlaxoSmithKline Revenue in Systemic Infection Treatment Business (2015-2020)
13.4.5 GlaxoSmithKline Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview
13.5.3 Novartis Systemic Infection Treatment Introduction
13.5.4 Novartis Revenue in Systemic Infection Treatment Business (2015-2020)
13.5.5 Novartis Recent Development
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Details
13.6.2 Johnson & Johnson Business Overview
13.6.3 Johnson & Johnson Systemic Infection Treatment Introduction
13.6.4 Johnson & Johnson Revenue in Systemic Infection Treatment Business (2015-2020)
13.6.5 Johnson & Johnson Recent Development
13.7 Sun Pharmaceuticals
13.7.1 Sun Pharmaceuticals Company Details
13.7.2 Sun Pharmaceuticals Business Overview
13.7.3 Sun Pharmaceuticals Systemic Infection Treatment Introduction
13.7.4 Sun Pharmaceuticals Revenue in Systemic Infection Treatment Business (2015-2020)
13.7.5 Sun Pharmaceuticals Recent Development
13.8 Roche
13.8.1 Roche Company Details
13.8.2 Roche Business Overview
13.8.3 Roche Systemic Infection Treatment Introduction
13.8.4 Roche Revenue in Systemic Infection Treatment Business (2015-2020)
13.8.5 Roche Recent Development
13.9 Astra Zeneca
13.9.1 Astra Zeneca Company Details
13.9.2 Astra Zeneca Business Overview
13.9.3 Astra Zeneca Systemic Infection Treatment Introduction
13.9.4 Astra Zeneca Revenue in Systemic Infection Treatment Business (2015-2020)
13.9.5 Astra Zeneca Recent Development
13.10 Wockhardt ltd
13.10.1 Wockhardt ltd Company Details
13.10.2 Wockhardt ltd Business Overview
13.10.3 Wockhardt ltd Systemic Infection Treatment Introduction
13.10.4 Wockhardt ltd Revenue in Systemic Infection Treatment Business (2015-2020)
13.10.5 Wockhardt ltd Recent Development
13.11 Mylan Pharma
10.11.1 Mylan Pharma Company Details
10.11.2 Mylan Pharma Business Overview
10.11.3 Mylan Pharma Systemic Infection Treatment Introduction
10.11.4 Mylan Pharma Revenue in Systemic Infection Treatment Business (2015-2020)
10.11.5 Mylan Pharma Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Systemic Infection Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Systemic Infection Treatment Revenue
Table 3. Ranking of Global Top Systemic Infection Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Systemic Infection Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Antibacterial
Table 6. Key Players of Antiviral
Table 7. Key Players of Antifungal
Table 8. Global Systemic Infection Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Systemic Infection Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Systemic Infection Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Systemic Infection Treatment Market Share by Regions (2015-2020)
Table 12. Global Systemic Infection Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Systemic Infection Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Systemic Infection Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Systemic Infection Treatment Players
Table 19. Global Systemic Infection Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Systemic Infection Treatment Market Share by Players (2015-2020)
Table 21. Global Top Systemic Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Systemic Infection Treatment as of 2019)
Table 22. Global Systemic Infection Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Systemic Infection Treatment Product Solution and Service
Table 25. Date of Enter into Systemic Infection Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Systemic Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Systemic Infection Treatment Market Size Share by Type (2015-2020)
Table 29. Global Systemic Infection Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Systemic Infection Treatment Market Size Share by Application (2015-2020)
Table 31. Global Systemic Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Systemic Infection Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Systemic Infection Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Systemic Infection Treatment Market Share (2019-2020)
Table 35. North America Systemic Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Systemic Infection Treatment Market Share by Type (2015-2020)
Table 37. North America Systemic Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Systemic Infection Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Systemic Infection Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Systemic Infection Treatment Market Share (2019-2020)
Table 41. Europe Systemic Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Systemic Infection Treatment Market Share by Type (2015-2020)
Table 43. Europe Systemic Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Systemic Infection Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Systemic Infection Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Systemic Infection Treatment Market Share (2019-2020)
Table 47. China Systemic Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Systemic Infection Treatment Market Share by Type (2015-2020)
Table 49. China Systemic Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Systemic Infection Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Systemic Infection Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Systemic Infection Treatment Market Share (2019-2020)
Table 53. Japan Systemic Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Systemic Infection Treatment Market Share by Type (2015-2020)
Table 55. Japan Systemic Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Systemic Infection Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Systemic Infection Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Systemic Infection Treatment Market Share (2019-2020)
Table 59. Southeast Asia Systemic Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Systemic Infection Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Systemic Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Systemic Infection Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Systemic Infection Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Systemic Infection Treatment Market Share (2019-2020)
Table 65. India Systemic Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Systemic Infection Treatment Market Share by Type (2015-2020)
Table 67. India Systemic Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Systemic Infection Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Systemic Infection Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Systemic Infection Treatment Market Share (2019-2020)
Table 71. Central & South America Systemic Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Systemic Infection Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Systemic Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Systemic Infection Treatment Market Share by Application (2015-2020)
Table 75. Abbott Laboratories Company Details
Table 76. Abbott Laboratories Business Overview
Table 77. Abbott Laboratories Product
Table 78. Abbott Laboratories Revenue in Systemic Infection Treatment Business (2015-2020) (Million US$)
Table 79. Abbott Laboratories Recent Development
Table 80. Merck & Co. Company Details
Table 81. Merck & Co. Business Overview
Table 82. Merck & Co. Product
Table 83. Merck & Co. Revenue in Systemic Infection Treatment Business (2015-2020) (Million US$)
Table 84. Merck & Co. Recent Development
Table 85. Pfizer Company Details
Table 86. Pfizer Business Overview
Table 87. Pfizer Product
Table 88. Pfizer Revenue in Systemic Infection Treatment Business (2015-2020) (Million US$)
Table 89. Pfizer Recent Development
Table 90. GlaxoSmithKline Company Details
Table 91. GlaxoSmithKline Business Overview
Table 92. GlaxoSmithKline Product
Table 93. GlaxoSmithKline Revenue in Systemic Infection Treatment Business (2015-2020) (Million US$)
Table 94. GlaxoSmithKline Recent Development
Table 95. Novartis Company Details
Table 96. Novartis Business Overview
Table 97. Novartis Product
Table 98. Novartis Revenue in Systemic Infection Treatment Business (2015-2020) (Million US$)
Table 99. Novartis Recent Development
Table 100. Johnson & Johnson Company Details
Table 101. Johnson & Johnson Business Overview
Table 102. Johnson & Johnson Product
Table 103. Johnson & Johnson Revenue in Systemic Infection Treatment Business (2015-2020) (Million US$)
Table 104. Johnson & Johnson Recent Development
Table 105. Sun Pharmaceuticals Company Details
Table 106. Sun Pharmaceuticals Business Overview
Table 107. Sun Pharmaceuticals Product
Table 108. Sun Pharmaceuticals Revenue in Systemic Infection Treatment Business (2015-2020) (Million US$)
Table 109. Sun Pharmaceuticals Recent Development
Table 110. Roche Business Overview
Table 111. Roche Product
Table 112. Roche Company Details
Table 113. Roche Revenue in Systemic Infection Treatment Business (2015-2020) (Million US$)
Table 114. Roche Recent Development
Table 115. Astra Zeneca Company Details
Table 116. Astra Zeneca Business Overview
Table 117. Astra Zeneca Product
Table 118. Astra Zeneca Revenue in Systemic Infection Treatment Business (2015-2020) (Million US$)
Table 119. Astra Zeneca Recent Development
Table 120. Wockhardt ltd Company Details
Table 121. Wockhardt ltd Business Overview
Table 122. Wockhardt ltd Product
Table 123. Wockhardt ltd Revenue in Systemic Infection Treatment Business (2015-2020) (Million US$)
Table 124. Wockhardt ltd Recent Development
Table 125. Mylan Pharma Company Details
Table 126. Mylan Pharma Business Overview
Table 127. Mylan Pharma Product
Table 128. Mylan Pharma Revenue in Systemic Infection Treatment Business (2015-2020) (Million US$)
Table 129. Mylan Pharma Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Systemic Infection Treatment Market Share by Type: 2020 VS 2026
Figure 2. Antibacterial Features
Figure 3. Antiviral Features
Figure 4. Antifungal Features
Figure 5. Global Systemic Infection Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Systemic Infection Treatment Report Years Considered
Figure 10. Global Systemic Infection Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Systemic Infection Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Systemic Infection Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Systemic Infection Treatment Market Share by Players in 2019
Figure 15. Global Top Systemic Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Systemic Infection Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Systemic Infection Treatment Revenue in 2019
Figure 17. North America Systemic Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Systemic Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Systemic Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Systemic Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Systemic Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Systemic Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Systemic Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
耳感染症治療の世界市場（～2026年） An ear infection occurs due to invasion by bacteria or virus causing pain, inflammation and fluid build-up in the ear. Most ear infections are acute but chronic ear infections can cause permanent damage to the middle and inner ear. Eustachian tubes, small tubes running from ear to the back of the th…- 尿路感染症治療の世界市場（～2026年） Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland. This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasin…
- 全身性特発性若年性関節炎治療の世界市場（～2026年） Market Analysis and Insights: Global Systemic Idiopathic Juvenile Arthritis Treatment Market The global Systemic Idiopathic Juvenile Arthritis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Systemic Idiopath…
- 下気道感染症治療の世界市場（～2026年） The infection below the level of larynx is said to be lower respiratory tract infection. Many a times, lower respiratory tract infection is called pneumonia. These infection are not defined uniformly, but epidemiologically, these infections includes flu, bronchitis, bronchiolitis, and pneumonia. The…
- 帯状疱疹感染症治療の世界市場（～2026年） Herpes Zoster (shingles) is a cutaneous, acute viral infection caused by the varicella-zoster virus. Herpes Zoster is the outbreak of rash on the skin that cause burning and pain. Herpes Zoster is caused by the same virus which cause chickenpox. The virus may live in your nervous system for many yea…